USA TODAYfull face transplant patient smilingHerald SunDallas Wiens was the only patient of the first three surgeries done in the US who did not suffer an acute rejection of the transplant within the first six months. The 25-year-old Wiens told the Dal…
BC-TX–Texas News DigestNECNDallas Wiens was the only patient of the first three surgeries done in the US who did not suffer an acute rejection of the transplant within the first six months. The 25-year-old Wiens can now smile and express emotion with …
Blackburn girl's body rejected lung transplant, inquest heardLancashire TelegraphShe told the inquest the cause of death was the chronic rejection of the lungs, and cystic fibrosis. Returning a narrative verdict, coroner Michael Singleton said: “…
Omni Bio to Conduct New Human Clinical TrialsMarketWatch (press release)Novel discoveries made at the University of Colorado Denver indicate that AAT has the potential to address a variety of indications in the areas of diabetes, transplant rejection a…
Insiders are Selling These Stocks ; Jan-12Beacon Equity Research… Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-threatening disease states, including hematologic and neurologic diseases, transplan…
Southington boy dies of heart failure 12 years after transplantMeriden Record-JournalHughes died Saturday from acute rejection at Bradley Memorial Hospital. "Every day an organ recipient is fighting," said Terri Clausen, Hughes' mother. A…
CHKM, ALXN, RDDY, HOLI, FSIN, EXAR are Stocks to Watch on Jan-10 AfternoonBeacon Equity ResearchTheir market cap is 13.82B . Alexion Pharmaceuticals, Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-th…
CHKM, ALXN, RDDY, HOLI, FSIN, EXAR are Stocks to Watch on Jan-9 AfternoonBeacon Equity ResearchTheir market cap is 13.82B . Alexion Pharmaceuticals, Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-thr…
52 Week Highs: AAPL, ACHN, ALOG, ALXN, AMSWA, ANLYTomRollins.com… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeutic areas of hemato…
Omni Bio Pharmaceutical to Present at Noble Financial Capital Markets' Eighth …MarketWatch (press release)Novel discoveries made at UCD indicate that AAT has the potential to address a variety of indications in the areas of diabetes, transplant r…